影响原发性膜性病的临床结果的临床共变量
Lukas Westermann1, Felix A Rottmann1, Martin J Hug2
1Department of Medicine IV, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
BMC nephrology
|August 10, 2023
概括
较高的血清白蛋白水平和循环胺治疗加速了原发性膜性病 (PMN) 的恢复. 高龄是PMN患者功能下降的危险因素.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
背景情况:
- 初级膜性病 (PMN) 是综合征和功能障碍的主要原因.
- 确定患者特异性和与治疗相关的因素对于PMN个性化治疗策略至关重要.
研究的目的:
- 分析患者特异性和与治疗相关的因素,影响蛋白尿,低albuminemia,和估计的膜过率 (eGFR) 在抗体阳性PMN.
- 确定PMN患者治疗反应和功能下降的预测因素.
主要方法:
- 74名患有抗体阳性PMN和脏范围蛋白尿症 (UPCR≥3.5g/g) 的患者的回顾性观察研究.
- 分析蛋白尿/血清白蛋白反应 (UPCR ≤ 0.5 g/g或血清白蛋白≥ 3.5 g/dl) 的时间和永久性EGFR下降 (≥ 40%) 的时间.
- 进行了多变量时间到事件分析,以评估共变量效应.
主要成果:
- 蛋白尿/血清白蛋白反应的中位时间为167天,永久性EGFR下降的时间为2413天.
- 较高的基线血清白蛋白水平 (HR 2.7) 和环胺治疗 (HR 3.6) 与显著更快的反应有关.
- 基线时的年龄较大与更快的eGFR下降显著相关 (HR 1.04).
结论:
- 高血清白蛋白水平和循环胺治疗与PMN中蛋白尿和白蛋白水平的改善有关.
- 高龄是PMN患者逐渐下降功能的一个重要危险因素.
- 这些发现支持个人化治疗建议和PMN患者的风险分层.
关键词:
慢性脏疾病 慢性脏疾病免疫抑制是一种免疫抑制.脏病综合征 - 脏病综合征在PLA2-R中,PLA2-R是指PLA2-R.一级膜性脏病主要的膜性脏病里图西马布 (Rituximab) 是一种药物.这就是THSD7A.更多相关视频
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.7K
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
2.9K
相关概念视频
01:24Chronic Kidney Disease II: Clinical Manifestations
30
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
30
01:26Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
01:24Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
82
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
82
01:17Factors Affecting Renal Clearance: Renal Impairment
119
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
119
01:29Acute Kidney Injury III: Clinical Manifestations
32
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
32